{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:04:03Z","timestamp":1792785843055,"version":"4.5.0"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T00:00:00Z","timestamp":1694390400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Coronafonds"},{"DOI":"10.13039\/501100003130","name":"FWO","doi-asserted-by":"publisher","award":["11M6922N"],"award-info":[{"award-number":["11M6922N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,2,17]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Coronavirus disease 2019 (COVID-19)\u2013associated pulmonary aspergillosis (CAPA) is a frequent superinfection in critically ill patients with COVID-19 and is associated with increased mortality rates. The increasing proportion of severely immunocompromised patients with COVID-19 who require mechanical ventilation warrants research into the incidence and impact of CAPA during the vaccination era.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We performed a retrospective, monocentric, observational study. We collected data from adult patients with severe COVID-19 requiring mechanical ventilation who were admitted to the intensive care unit (ICU) of University Hospitals Leuven, a tertiary referral center, between 1 March 2020 and 14 November 2022. Probable or proven CAPA was diagnosed according to the 2020 European Confederation for Medical Mycology\/International Society for Human and Animal Mycology (ECMM\/ISHAM) criteria.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We included 335 patients. Bronchoalveolar lavage sampling was performed in 300 (90%), and CAPA was diagnosed in 112 (33%). The incidence of CAPA was 62% (50 of 81 patients) in European Organisation for Research and Treatment of Cancer (EORTC)\/Mycosis Study Group Education and Research Consortium (MSGERC) host factor\u2013positive patients, compared with 24% (62 of 254) in host factor\u2013negative patients. The incidence of CAPA was significantly higher in the vaccination era, increasing from 24% (57 of 241) in patients admitted to the ICU before October 2021 to 59% (55 of 94) in those admitted since then. Both EORTC\/MSGERC host factors and ICU admission in the vaccination era were independently associated with CAPA development. CAPA remained an independent risk factor associated with mortality risk during the vaccination era.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The presence of EORTC\/MSGERC host factors for invasive mold disease is associated with increased CAPA incidence and worse outcome parameters, and it is the main driver for the significantly higher incidence of CAPA in the vaccination era. Our findings warrant investigation of antifungal prophylaxis in critically ill patients with COVID-19.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/cid\/ciad546","type":"journal-article","created":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T16:53:02Z","timestamp":1694191982000},"page":"361-370","source":"Crossref","is-referenced-by-count":48,"title":["High Burden of COVID-19-Associated Pulmonary Aspergillosis in Severely Immunocompromised Patients Requiring Mechanical Ventilation"],"prefix":"10.1093","volume":"78","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7516-9471","authenticated-orcid":false,"given":"Simon","family":"Feys","sequence":"first","affiliation":[{"name":"Medical Intensive Care Unit, University Hospitals Leuven , Leuven , Belgium"},{"name":"Department of Microbiology, Immunology and Transplantation, KU Leuven , Leuven , Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrien","family":"Lagrou","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Immunology and Transplantation, KU Leuven , Leuven , Belgium"},{"name":"Department of Laboratory Medicine and National Reference Center for Mycosis, University Hospitals Leuven , Leuven , Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanne Moon","family":"Lauwers","sequence":"additional","affiliation":[{"name":"Medical Intensive Care Unit, University Hospitals Leuven , Leuven , Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koen","family":"Haenen","sequence":"additional","affiliation":[{"name":"Medical Intensive Care Unit, University Hospitals Leuven , Leuven , Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cato","family":"Jacobs","sequence":"additional","affiliation":[{"name":"Medical Intensive Care Unit, University Hospitals Leuven , Leuven , Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marius","family":"Brusselmans","sequence":"additional","affiliation":[{"name":"Leuven Biostatistics and Statistical Bioinformatics Center (L-BioStat), KU Leuven , Leuven , Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Debaveye","sequence":"additional","affiliation":[{"name":"Department of Intensive Care Medicine, University Hospitals Leuven , Leuven , Belgium"},{"name":"Department of Cellular and Molecular Medicine, KU Leuven , Leuven , Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greet","family":"Hermans","sequence":"additional","affiliation":[{"name":"Medical Intensive Care Unit, University Hospitals Leuven , Leuven , Belgium"},{"name":"Department of Cellular and Molecular Medicine, KU Leuven , Leuven , Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Hoenigl","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, ECMM Excellence Center, Department of Internal Medicine, Medical University of Graz , Graz , Austria"},{"name":"Bio TechMed , Graz , Austria"},{"name":"Translational Medical Mycology Research Group, Medical University of Graz , Graz , Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Maertens","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Immunology and Transplantation, KU Leuven , Leuven , Belgium"},{"name":"Department of Hematology, University Hospitals Leuven , Leuven , Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Meersseman","sequence":"additional","affiliation":[{"name":"Medical Intensive Care Unit, University Hospitals Leuven , Leuven , Belgium"},{"name":"Department of Microbiology, Immunology and Transplantation, KU Leuven , Leuven , Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marijke","family":"Peetermans","sequence":"additional","affiliation":[{"name":"Medical Intensive Care Unit, University Hospitals Leuven , Leuven , Belgium"},{"name":"Department of Microbiology, Immunology and Transplantation, KU Leuven , Leuven , Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Spriet","sequence":"additional","affiliation":[{"name":"Pharmacy Department, University Hospitals Leuven , Leuven , Belgium"},{"name":"Department of Pharmaceutical and Pharmacological Sciences, KU Leuven , Leuven , Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Vandenbriele","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Diseases, University Hospitals Leuven , Leuven , Belgium"},{"name":"Department of Cardiovascular Sciences, KU Leuven , Leuven , Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lore","family":"Vanderbeke","sequence":"additional","affiliation":[{"name":"Department of General Internal Medicine, University Hospitals Leuven , Leuven , Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Vos","sequence":"additional","affiliation":[{"name":"Department of Respiratory Diseases, University Hospitals Leuven , Leuven , Belgium"},{"name":"Department of Chronic Diseases and Metabolism, KU Leuven , Leuven , Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Van Wijngaerden","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Immunology and Transplantation, KU Leuven , Leuven , Belgium"},{"name":"Department of General Internal Medicine, University Hospitals Leuven , Leuven , Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Wilmer","sequence":"additional","affiliation":[{"name":"Medical Intensive Care Unit, University Hospitals Leuven , Leuven , Belgium"},{"name":"Department of Microbiology, Immunology and Transplantation, KU Leuven , Leuven , Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joost","family":"Wauters","sequence":"additional","affiliation":[{"name":"Medical Intensive Care Unit, University Hospitals Leuven , Leuven , Belgium"},{"name":"Department of Microbiology, Immunology and Transplantation, KU Leuven , Leuven , Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,9,11]]},"reference":[{"key":"2024021719314589000_ciad546-B1","author":"World Health Organization."},{"key":"2024021719314589000_ciad546-B2","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1001\/jama.2023.5348","article-title":"Risk of death in patients hospitalized for COVID-19 versus seasonal influenza in fall-winter 2022\u20132023","volume":"329","author":"Xie","year":"2023","journal-title":"JAMA"},{"key":"2024021719314589000_ciad546-B3","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/S0140-6736(22)01656-7","article-title":"Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters: pooled analysis of national prospective cohort studies of 30 million individuals in England, Northern Ireland, Scotland, and Wales","volume":"400","author":"Agrawal","year":"2022","journal-title":"Lancet"},{"key":"2024021719314589000_ciad546-B4","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1093\/cid\/ciaa863","article-title":"COVID-19 in immunocompromised hosts: what we know so far","volume":"72","author":"Fung","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2024021719314589000_ciad546-B5","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1001\/jamainternmed.2021.7024","article-title":"Association between immune dysfunction and COVID-19 breakthrough infection after SARS-CoV-2 vaccination in the US","volume":"182","author":"Sun","year":"2022","journal-title":"JAMA Intern Med"},{"key":"2024021719314589000_ciad546-B6","doi-asserted-by":"crossref","first-page":"e068632","DOI":"10.1136\/bmj-2021-068632","article-title":"Efficacy of COVID-19 vaccines in immunocompromised patients: systematic review and meta-analysis","volume":"376","author":"Lee","year":"2022","journal-title":"BMJ"},{"key":"2024021719314589000_ciad546-B7","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1038\/s41564-022-01172-2","article-title":"COVID-19-associated fungal infections","volume":"7","author":"Hoenigl","year":"2022","journal-title":"Nat Microbiol"},{"key":"2024021719314589000_ciad546-B8","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1007\/s00134-021-06510-2","article-title":"COVID-19 associated pulmonary aspergillosis: regional variation in incidence and diagnostic challenges","volume":"47","author":"Prattes","year":"2021","journal-title":"Intensive Care Med"},{"key":"2024021719314589000_ciad546-B9","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S2213-2600(21)00442-2","article-title":"Fungal infections in mechanically ventilated patients with COVID-19 during the first wave: the French multicentre MYCOVID study","volume":"10","author":"Gangneux","year":"2022","journal-title":"Lancet Respir Med"},{"key":"2024021719314589000_ciad546-B10","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.3201\/eid2711.211174","article-title":"Multinational observational cohort study of COVID-19\u2013associated pulmonary aspergillosis","volume":"27","author":"Janssen","year":"2021","journal-title":"Emerg Infect Dis"},{"key":"2024021719314589000_ciad546-B11","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the European Organisation for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2024021719314589000_ciad546-B12","doi-asserted-by":"crossref","first-page":"P1147","DOI":"10.1016\/S2213-2600(22)00259-4","article-title":"Lung epithelial and myeloid innate immunity in influenza-associated or COVID-19-associated pulmonary aspergillosis: an observational study","volume":"10","author":"Feys","year":"2022","journal-title":"Lancet Respir Med"},{"key":"2024021719314589000_ciad546-B13","doi-asserted-by":"crossref","first-page":"eabq6682","DOI":"10.1126\/scitranslmed.abq6682","article-title":"A B1a\u2013natural IgG\u2013neutrophil axis is impaired in viral- and steroid-associated aspergillosis","volume":"14","author":"Sarden","year":"2022","journal-title":"Sci Transl Med"},{"key":"2024021719314589000_ciad546-B14","doi-asserted-by":"crossref","first-page":"954985","DOI":"10.3389\/fimmu.2022.954985","article-title":"COVID-19 patients share common, corticosteroid-independent features of impaired host immunity to pathogenic molds","volume":"13","author":"Tappe","year":"2022","journal-title":"Front Immunol"},{"key":"2024021719314589000_ciad546-B15","doi-asserted-by":"crossref","first-page":"e0122921","DOI":"10.1128\/JCM.01229-21","article-title":"Aspergillus test profiles and mortality in critically ill COVID-19 patients","volume":"59","author":"Erg\u00fcn","year":"2021","journal-title":"J Clin Microbiol"},{"key":"2024021719314589000_ciad546-B16","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1164\/rccm.202009-3400OC","article-title":"Occurrence of invasive pulmonary fungal infections in patients with severe COVID-19 admitted to the ICU","volume":"203","author":"Fekkar","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"2024021719314589000_ciad546-B17","doi-asserted-by":"crossref","first-page":"154272","DOI":"10.1016\/j.jcrc.2023.154272","article-title":"Incidence, risk factors and pre-emptive screening for COVID-19 associated pulmonary aspergillosis in an era of immunomodulant therapy","volume":"76","author":"van Grootveld","year":"2023","journal-title":"J Crit Care"},{"key":"2024021719314589000_ciad546-B18","doi-asserted-by":"crossref","first-page":"e149","DOI":"10.1016\/S1473-3099(20)30847-1","article-title":"Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM\/ISHAM consensus criteria for research and clinical guidance","volume":"21","author":"Koehler","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"2024021719314589000_ciad546-B19","volume-title":"COVID-19 clinical hospital surveillance report","author":"De Mot","year":"2023"},{"key":"2024021719314589000_ciad546-B20","author":"Sciensano"},{"key":"2024021719314589000_ciad546-B21","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1111\/myc.13485","article-title":"New insights into development and mortality of COVID-19-associated pulmonary aspergillosis in a homogenous cohort of 1161 intensive care patients","volume":"65","author":"Hashim","year":"2022","journal-title":"Mycoses"},{"key":"2024021719314589000_ciad546-B22","doi-asserted-by":"crossref","first-page":"948","DOI":"10.3390\/jof7110948","article-title":"COVID-19-associated pulmonary aspergillosis: a single-center experience in central valley, California, January 2020\u2013March 2021","volume":"7","author":"Sivasubramanian","year":"2021","journal-title":"J Fungi (Basel)"},{"key":"2024021719314589000_ciad546-B23","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13054-022-03902-8","article-title":"Corticosteroids as risk factor for COVID-19-associated pulmonary aspergillosis in intensive care patients","volume":"26","author":"Leistner","year":"2022","journal-title":"Crit Care"},{"key":"2024021719314589000_ciad546-B24","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/myc.13430","article-title":"COVID-19-associated pulmonary aspergillosis in ICU patients in a German reference centre: phenotypic and molecular characterisation of Aspergillus fumigatus isolates","volume":"65","author":"Kirchhoff","year":"2022","journal-title":"Mycoses"},{"key":"2024021719314589000_ciad546-B25","doi-asserted-by":"crossref","first-page":"790.e1","DOI":"10.1016\/j.cmi.2020.12.005","article-title":"Risk factors associated with COVID-19-associated pulmonary aspergillosis in ICU patients: a French multicentric retrospective cohort","volume":"27","author":"Delli\u00e8re","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"2024021719314589000_ciad546-B26","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.52586\/5053","article-title":"Potential links between COVID-19-associated pulmonary aspergillosis and bronchiectasis as detected by high resolution computed tomography","volume":"26","author":"Baratella","year":"2021","journal-title":"Front Biosci (Landmark Ed)"},{"key":"2024021719314589000_ciad546-B27","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3390\/jof8020093","article-title":"COVID-19 associated pulmonary aspergillosis: diagnostic performance, fungal epidemiology and antifungal susceptibility","volume":"8","author":"Lackner","year":"2022","journal-title":"J Fungi (Basel)"},{"key":"2024021719314589000_ciad546-B28","first-page":"e16982","article-title":"COVID-associated pulmonary aspergillosis and its related outcomes: a single-center prospective observational study","volume":"13","author":"Iqbal","year":"2021","journal-title":"Cureus"},{"key":"2024021719314589000_ciad546-B29","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3390\/jof8020097","article-title":"COVID-19-associated pulmonary aspergillosis in a tertiary hospital","volume":"8","author":"Garc\u00eda-Clemente","year":"2022","journal-title":"J Fungi (Basel)"},{"key":"2024021719314589000_ciad546-B30","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.3390\/jof7121067","article-title":"A visual and comprehensive review on COVID-19-associated pulmonary aspergillosis (CAPA)","volume":"7","author":"Feys","year":"2021","journal-title":"J Fungi"},{"key":"2024021719314589000_ciad546-B31","doi-asserted-by":"crossref","first-page":"e0696","DOI":"10.1097\/CCE.0000000000000696","article-title":"Nebulized amphotericin B in mechanically ventilated COVID-19 patients to prevent invasive pulmonary aspergillosis: a retrospective cohort study","volume":"4","author":"Melchers","year":"2022","journal-title":"Crit Care Explor"},{"key":"2024021719314589000_ciad546-B32","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1186\/s13054-021-03753-9","article-title":"Antifungal prophylaxis for prevention of COVID-19-associated pulmonary aspergillosis in critically ill patients: an observational study","volume":"25","author":"Hatzl","year":"2021","journal-title":"Critical Care"},{"key":"2024021719314589000_ciad546-B33","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1186\/s13054-021-03728-w","article-title":"Inhaled liposomal amphotericin-B as a prophylactic treatment for COVID-19-associated pulmonary aspergillosis\/aspergillus tracheobronchitis","volume":"25","author":"Van Ackerbroeck","year":"2021","journal-title":"Critical Care"},{"key":"2024021719314589000_ciad546-B34","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/s00134-021-06603-y","article-title":"Inhaled amphotericin B lipid complex for prophylaxis against COVID-19-associated invasive pulmonary aspergillosis","volume":"48","author":"Soriano","year":"2022","journal-title":"Intensive Care Med"},{"key":"2024021719314589000_ciad546-B35","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1097\/MCC.0000000000000977","article-title":"COVID-19-associated pulmonary aspergillosis: an underdiagnosed or overtreated infection?","volume":"28","author":"Rouz\u00e9","year":"2022","journal-title":"Curr Opin Crit Care"},{"key":"2024021719314589000_ciad546-B36","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jcrc.2020.07.002","article-title":"Late histopathologic characteristics of critically ill COVID-19 patients: different phenotypes without evidence of invasive aspergillosis, a case series","volume":"59","author":"Flikweert","year":"2020","journal-title":"J Crit Care"},{"key":"2024021719314589000_ciad546-B37","doi-asserted-by":"crossref","first-page":"e405","DOI":"10.1016\/S2666-5247(21)00091-4","article-title":"Invasive mould disease in fatal COVID-19: a systematic review of autopsies","volume":"2","author":"Kula","year":"2021","journal-title":"Lancet Microbe"},{"key":"2024021719314589000_ciad546-B38","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1164\/rccm.202208-1570OC","article-title":"A pathology-based case series of influenza- and COVID-19-associated pulmonary aspergillosis: the proof is in the tissue","volume":"208","author":"Vanderbeke","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"2024021719314589000_ciad546-B39","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1111\/myc.13342","article-title":"Proven COVID-19\u2013associated pulmonary aspergillosis in patients with severe respiratory failure","volume":"64","author":"Fortarezza","year":"2021","journal-title":"Mycoses"},{"key":"2024021719314589000_ciad546-B40","doi-asserted-by":"crossref","first-page":"894","DOI":"10.3390\/jof8090894","article-title":"Challenges in diagnosing COVID-19-associated pulmonary aspergillosis in critically ill patients: the relationship between case definitions and autoptic data","volume":"8","author":"Casalini","year":"2022","journal-title":"J Fungi (Basel)"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciad546\/52009089\/ciad546.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/78\/2\/361\/56697776\/ciad546.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/78\/2\/361\/56697776\/ciad546.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,17]],"date-time":"2024-02-17T14:32:35Z","timestamp":1708180355000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/78\/2\/361\/7267431"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,11]]},"references-count":40,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,9,11]]},"published-print":{"date-parts":[[2024,2,17]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciad546","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,2,15]]},"published":{"date-parts":[[2023,9,11]]}}}